Literature DB >> 15720253

Recent developments on KCNQ potassium channel openers.

Yong-Jin Wua1, Steven I Dworetzky.   

Abstract

During the past five years, several members of the KCNQ potassium channel gene family have been identified with a high degree of CNS specificity. Within the KCNQ family, the combination of the KCNQ2/KCNQ3 proteins, and the KCNQ5/KCNQ3 arrangement has been identified as the molecular correlates of the different M-currents. Several lines of evidence are emerging demonstrating the importance of these channels in regulating neuronal excitability; for example, determination of the excitability threshold, firing properties, and responsiveness of neurons to synaptic inputs. Recent studies have shown that KCNQ openers have potential for the treatment of several CNS disorders characterized by neuronal hyperexcitability, such as migraine, epilepsy and neuropathic pain. This article reviews the recent developments of KCNQ potassium channel openers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15720253     DOI: 10.2174/0929867053363045

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  21 in total

1.  Chronic deficit in the expression of voltage-gated potassium channel Kv3.4 subunit in the hippocampus of pilocarpine-treated epileptic rats.

Authors:  Luis F Pacheco Otalora; Frank Skinner; Mauro S Oliveira; Bianca Farrell; Massoud F Arshadmansab; Tarun Pandari; Ileana Garcia; Leslie Robles; Gerardo Rosas; Carlos F Mello; Boris S Ermolinsky; Emilio R Garrido-Sanabria
Journal:  Brain Res       Date:  2010-10-21       Impact factor: 3.252

2.  Phosphatidylinositol 4,5-bisphosphate alters pharmacological selectivity for epilepsy-causing KCNQ potassium channels.

Authors:  Pingzheng Zhou; Haibo Yu; Min Gu; Fa-jun Nan; Zhaobing Gao; Min Li
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

3.  Potassium channel modulators as possible treatment for pain: patent highlight.

Authors:  Ahmed F Abdel-Magid
Journal:  ACS Med Chem Lett       Date:  2012-07-10       Impact factor: 4.345

Review 4.  Molecular targets for antiepileptic drug development.

Authors:  Brian S Meldrum; Michael A Rogawski
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

5.  Satellite glial cells in the trigeminal ganglion as a determinant of orofacial neuropathic pain.

Authors:  Jean-Philippe Vit; Luc Jasmin; Aditi Bhargava; Peter T Ohara
Journal:  Neuron Glia Biol       Date:  2006-11

Review 6.  Voltage-gated potassium channels as therapeutic targets.

Authors:  Heike Wulff; Neil A Castle; Luis A Pardo
Journal:  Nat Rev Drug Discov       Date:  2009-12       Impact factor: 84.694

7.  Sequence determinants of subtype-specific actions of KCNQ channel openers.

Authors:  Alice W Wang; Runying Yang; Harley T Kurata
Journal:  J Physiol       Date:  2016-09-23       Impact factor: 5.182

8.  Silencing the Kir4.1 potassium channel subunit in satellite glial cells of the rat trigeminal ganglion results in pain-like behavior in the absence of nerve injury.

Authors:  Jean-Philippe Vit; Peter T Ohara; Aditi Bhargava; Kanwar Kelley; Luc Jasmin
Journal:  J Neurosci       Date:  2008-04-16       Impact factor: 6.167

9.  Molecular Mechanisms and Structural Basis of Retigabine Analogues in Regulating KCNQ2 Channel.

Authors:  Sai Shi; Junwei Li; Fude Sun; Yafei Chen; Chunli Pang; Yizhao Geng; Jinlong Qi; Shuai Guo; Xuzhao Wang; Hailin Zhang; Yong Zhan; Hailong An
Journal:  J Membr Biol       Date:  2020-03-13       Impact factor: 1.843

Review 10.  Potassium Channels in Epilepsy.

Authors:  Rüdiger Köhling; Jakob Wolfart
Journal:  Cold Spring Harb Perspect Med       Date:  2016-05-02       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.